publication venue for
- Corrigendum to 'A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States' [Gynecologic Oncology 159 (2020) 344-353].. 163:614-614. 2021
- Erratum to 'A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States' [Gynecologic Oncology 159 (2020) 344-353].. 161:913-614. 2021
- A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States.. 159:344-353. 2020
- Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancer.. 154:218-227. 2019
- High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome.. 141:348-356. 2016
- Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays.. 138:181-189. 2015
- SERPINB3 in the chicken model of ovarian cancer: A novel biomarker for predicting platinum resistance and survival in patients with epithelial ovarian cancer. 125:S43-S44. 2012
- Confocal microscopy: imaging cervical precancerous lesions.. 99:S84-S88. 2005
- Fluorescent nanocrystals for use in early cervical cancer detection.. 99:S89-S94. 2005
- Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer.. 93:361-365. 2004